Order Article Reprints

Yamana Y, Kanda T, Matsumoto N, Honda M, Kumagawa M, Sasaki R, Kanezawa S, Mizutani T, Yamagami H, Masuzaki R, et al. Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan. Journal of Clinical Medicine. 2021; 10(23):5529. https://doi.org/10.3390/jcm10235529

Yamana, Yoichiro, Tatsuo Kanda, Naoki Matsumoto, Masayuki Honda, Mariko Kumagawa, Reina Sasaki, Shini Kanezawa, Taku Mizutani, Hiroaki Yamagami, Ryota Masuzaki, and et al. 2021. "Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan" Journal of Clinical Medicine 10, no. 23: 5529. https://doi.org/10.3390/jcm10235529

Yamana, Y., Kanda, T., Matsumoto, N., Honda, M., Kumagawa, M., Sasaki, R., Kanezawa, S., Mizutani, T., Yamagami, H., Masuzaki, R., Ishii, T., Nirei, K., & Moriyama, M. (2021). Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan. Journal of Clinical Medicine, 10(23), 5529. https://doi.org/10.3390/jcm10235529